Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-12-05
2006-12-05
Zucker, Paul A. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S171000, C514S182000, C514S844000
Reexamination Certificate
active
07144875
ABSTRACT:
The invention is directed to methods of treating fungal and yeast infections using lupeol or solvates, hydrates, or clathrates thereof. The method also encompasses methods of treating fungal and yeast infections by administering to a mammal in need of such treatment a therapeutically effective amount of lupeol. Among the methods used include topical formulations for the improvement of skin appearance.
REFERENCES:
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 5750578 (1998-05-01), Carlson et al.
patent: 5837726 (1998-11-01), Liu et al.
patent: 6303589 (2001-10-01), Glinski et al.
patent: 6642217 (2003-11-01), Krasutsky et al.
patent: 6951847 (2005-10-01), Gibson et al.
patent: 98/46207 (1998-10-01), None
patent: 05-186326 (1993-07-01), None
patent: WO-9634005 (1996-10-01), None
patent: WO-9703995 (1997-02-01), None
patent: WO-98/32443 (1998-07-01), None
patent: WO-98/52573 (1998-11-01), None
patent: WO-00/24762 (2000-05-01), None
patent: WO-00/33846 (2000-06-01), None
patent: WO-00/46235 (2000-08-01), None
Aldrich Chemical Co. 2000-2001 Catalog, 871.
Merck Index, Twelfth edition (1996), 1236.
Chen, X, et al., “Induction of Acquired Resistance in Bean Plants AgainstPythium ultimumFungal Infection by 9,10-epoxy, 18-hydroxy octadecanoic acid”,University of Minnesota Duluth, Sixteenth Annual Sigma XI-Duluth Scientific Poster Exhibition, (Feb. 21, 2000), 1 page.
Gennaro, A R.,Remington's Pharmaceutical Sciences, Mack Pub. Co., 18th ed.,(1990), 384-386.
Keyel, P A., et al., “In Vitro Effect Acyclovir, Betulin and Cyclodextrin Solutions with Different Ionic Strengths Against Herpes Simplex Virus Infections”,University of Minnesota Duluth, Sixteenth Annual Sigma XI-Duluth Scientific Poster Exhibition, (Feb. 21, 2000), 1 page.
Koch, B R., et al., “Antibacterial Activity of Structural analogs of Betulin AgainstEscherichia coli, Bacillus subtilis, and Methicillin-ResistantStaphylococcus aureus”, University of Minnesota Duluth, Sixteenth Annual Sigma XI-Duluth Scientific Poster Exhibition,(Feb. 21, 2000), 1 page.
Nayar, V, et al., “Effectiveness of Triterpenoid Compounds and Polyethyleneimine Derivatives of Betulin Against Human PathogenicCandidaSpecies”,University of Minnesota Duluth, Sixteenth Annual Sigma XI-Duluth Scientific Poster Exhibition,(Feb. 21, 2000), 1 page.
Verma, D. K., et al., “Antimicrobial Active Triterpenoids FromLantanaSpecies”,Indian Drugs, vol. 34, No. 7, XP002115069, (1997),390-392.
Carlson Robert M.
Gibson David J.
Regents of the University of Minnesota
Schwegman Lundberg Woessner & Kluth P.A.
Zucker Paul A.
LandOfFree
Methods of treating fungal infections using lupeol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating fungal infections using lupeol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating fungal infections using lupeol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3700130